First Manhattan
RGNX icon

First Manhattan’s Regenxbio RGNX Stock Holding History

First Manhattan’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,600
Closed -$124K – 695
2024
Q2 		$124K Hold
10,600
– – ﹤0.01% 644
2024
Q1 		$223K Hold
10,600
– – ﹤0.01% 636
2023
Q4 		$190K Sell
10,600
-573,030
-98% -$10.1M ﹤0.01% 652
2023
Q3 		$9.61M Buy
583,630
+34,500
+6% +$625K 0.04% 147
2023
Q2 		$11M Buy
549,130
+101,400
+23% +$1.95M 0.04% 128
2023
Q1 		$8.47M Buy
447,730
+10,600
+2% +$235K 0.03% 157
2022
Q4 		$9.91M Sell
437,130
-268,600
-38% -$6.07M 0.04% 152
2022
Q3 		$18.7M Hold
705,730
– – 0.08% 101
2022
Q2 		$17.4M Buy
705,730
+9,365
+1% +$234K 0.07% 110
2022
Q1 		$23.1M Buy
696,365
+105,305
+18% +$2.93M 0.08% 105
2021
Q4 		$19.3M Buy
591,060
+22,792
+4% +$776K 0.06% 119
2021
Q3 		$23.8M Buy
568,268
+174,700
+44% +$6.29M 0.09% 100
2021
Q2 		$15.3M Buy
393,568
+60,178
+18% +$2.15M 0.06% 132
2021
Q1 		$11.4M Sell
333,390
-25,800
-7% -$1.1M 0.05% 147
2020
Q4 		$16.3M Buy
359,190
+259,847
+262% +$9.08M 0.08% 118
2020
Q3 		$2.73M Buy
99,343
+12,835
+15% +$418K 0.01% 268
2020
Q2 		$3.19M Sell
86,508
-1,700
-2% -$63.4K 0.02% 256
2020
Q1 		$2.86M Buy
+88,208
New +$3.68M 0.02% 264

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

First Manhattan's RGNX Position: Q3 2024 in Review

First Manhattan sold out of Regenxbio (RGNX) in Q3 2024, closing a stake of 10,600 shares — an estimated $124K sold.

First Manhattan first reported a position in RGNX in Q1 2020 and held it in 18 quarters. The position peaked at $23.8M in Q3 2021. 186 funds tracked by Wall St. Rank hold RGNX as of Q3 2024.

  • First Manhattan reported no remaining Regenxbio position as of Q3 2024 after selling out during the quarter.
  • First Manhattan sold 10,600 Regenxbio shares in Q3 2024, an estimated $124K.
  • First Manhattan first reported a position in Regenxbio in Q1 2020 and held it in 18 quarters.
  • First Manhattan's Regenxbio position peaked at $23.8M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Regenxbio as of Q3 2024.

Based on First Manhattan's 13F filing for Q3 2024, filed 14 Nov 2024.